The working group’s members from government and industry will assist with implementation of the National Strategy for a Resilient Public Health Supply Chain. Pratt oversees supply chain issues as Senior Vice President (SVP) in AdvaMed’s global policy department.
“Without access to component parts, ranging from high-tech semiconductor chips to basic papers and resins, our members are struggling to meet the demands of our health care system, potentially impacting the health and wellbeing of millions of Americans,” she said in a news release. “I am grateful for the opportunity to work with members of this public-private working group to address issues impacting our industry and to help ensure our supply chain is secure for patients in need.”
AdvaMed President and CEO Scott Whitaker called it “an important opportunity for us all to work together to find solutions that support the patients we serve.”
“Supply chain issues, especially those related to semiconductor chips, have become a critical challenge for medtech companies working to develop life-saving technologies for patients,” Scott Whitaker said in the news release. “We are facing a potential health care crisis if we fail to address these outstanding shortages and plan for the future.”
MedTech CEOs and AdvaMed recently met with the Biden administration to push for prioritization for short supplies like semiconductors.
REFERENCE: Medical Device and Outsourcing; 19 MAY 2022; Jim Hammerand